Literature DB >> 9504786

Early and severe neurological features in a Wilson disease patient compound heterozygous for two frameshift mutations.

A Angius1, V Dessi, M Lovicu, S De Virgiliis, M Pirastu, A Cao.   

Abstract

UNLABELLED: We describe a patient with Wilson disease who presented at 11 years of age with neurological symptoms and subsequent rapid progression of neurological impairment but absent hepatic manifestations. Molecular analysis showed compound heterozygosity for two frameshift mutations, 2299insC and 214delAT, which most likely result in an absent or inactive protein product. Mutation-phenotypic analysis indicates that this genotype does not explain the severe phenotype, suggesting the presence of modifying factors.
CONCLUSION: Wilson disease may present even in childhood or adolescence with neurological abnormalities in the absence of hepatic manifestations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504786     DOI: 10.1007/s004310050783

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  Homozygosity for Non-H1069Q Missense Mutations in ATP7B Gene and Early Severe Liver Disease: Report of Two Families and a Meta-analysis.

Authors:  Julnar Usta; Hussein Abu Daya; Houssam Halawi; Ibraheem Al-Shareef; Omar El-Rifai; Ahmad H Malli; Ala I Sharara; Robert H Habib; Kassem Barada
Journal:  JIMD Rep       Date:  2011-11-08

2.  Acute putaminal necrosis and white matter demyelination in a child with subnormal copper metabolism in Wilson disease: MR imaging and spectroscopic findings.

Authors:  Chun-Jung Juan; Cheng-Yu Chen; Yi-Jui Liu; Hsiao-Wen Chung; Shy-Chy Chin; Chun-Jen Hsueh; Hsin Chu; Robert A Zimmerman
Journal:  Neuroradiology       Date:  2005-05-21       Impact factor: 2.804

3.  Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease.

Authors:  Mario Piga; Alessandra Murru; Loredana Satta; Alessandra Serra; Alessandro Sias; Gianluigi Loi; Francesco Marrosu; Luigi Demelia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-08       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.